At a Glance
Half Year Results for the Six Months Ended 31 December 2019
- Update on 2019 AGM resolution vote 26 May 2020
- Clinigen signs exclusive agreement with Xeris Pharmaceuticals to supply and distribute Gvoke™ outside the US 14 May 2020
- IL-2 plays role in emerging TIL therapies 04 May 2020
The Group has a complementary portfolio of businesses operating globally, enhancing our ability to provide access to medicines worldwide.